Dec 20, 2017
Often entrepreneurs are describing their new company as a digital health start up, but what exactly is digital health? Some incorrectly think it is anything medical with a website or connected to an iPad. In his book, The Fourth Wave, Paul Sonnier describes it as...
Dec 13, 2017
At Locust Walk, we are often tasked with addressing complex strategic business issues for our biopharma clients. Perhaps one of the most common dilemmas is how best to optimize a given company’s clinical development strategy to maximize value. Specifically, many...
Dec 6, 2017
Term sheet negotiations are rarely easy, and there are multiple ways negotiations can break down before a deal is reached. Like many things in the biopharma industry, a big success factor in successful term sheet negotiations is effective communication. Below are some...
Nov 30, 2017
Having lived in Japan for more than 20 years, I have admittedly become perhaps a little too accustomed to the Japanese lifestyle. This is probably why after a few days in the hustle and bustle of Shanghai, I find myself looking forward to returning to the peace and...
Nov 21, 2017
Emerging biopharma companies with promising lead candidates in late-stage trials are often faced with a fundamental decision: go-it-alone (self-commercialize) or secure a strategic partner to support development and commercialization. It is a classic strategic choice...